Ovid Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
CEOMargaret Alexander
CEOMargaret Alexander
Employees23
Employees23
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees23
Employees23
OVID Key Statistics
Market cap192.02M
Market cap192.02M
Price-Earnings ratio-2.88
Price-Earnings ratio-2.88
Dividend yield—
Dividend yield—
Average volume916.23K
Average volume916.23K
High today$1.55
High today$1.55
Low today$1.47
Low today$1.47
Open price$1.51
Open price$1.51
Volume602.31K
Volume602.31K
52 Week high$2.01
52 Week high$2.01
52 Week low$0.2425
52 Week low$0.2425
Stock Snapshot
The current Ovid Therapeutics(OVID) stock price is $1.50, with a market capitalization of 192.02M. The stock trades at a price-to-earnings (P/E) ratio of -2.88.
During the trading session on 2026-02-22, Ovid Therapeutics(OVID) shares reached a daily high of $1.55 and a low of $1.47. At a current price of $1.50, the stock is +2.0% higher than the low and still -3.2% under the high.
Trading activity shows a volume of 602.31K, compared to an average daily volume of 916.23K.
Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.
Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.